InvestorsObserver
×
News Home

Is Editas Medicine Inc (EDIT) Stock a Bad Value Wednesday?

Wednesday, November 29, 2023 12:05 PM | InvestorsObserver Analysts

Mentioned in this article

Is Editas Medicine Inc (EDIT) Stock a Bad Value Wednesday?

Editas Medicine Inc (EDIT) is around the top of the Healthcare sector according to InvestorsObserver. EDIT received an overall rating of 68, which means that it scores higher than 68% of stocks. Additionally, Editas Medicine Inc scored a 80 in the Healthcare sector, ranking it higher than 80% of stocks in that sector.

Overall Score - 68
EDIT has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on EDIT!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 68 means the stock is more attractive than 68 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Editas Medicine Inc Stock Today?

Editas Medicine Inc (EDIT) stock is trading at $10.90 as of 12:05 PM on Wednesday, Nov 29, a rise of $0.16, or 1.49% from the previous closing price of $10.74. The stock has traded between $10.72 and $11.21 so far today. Volume today is below average. So far 787,118 shares have traded compared to average volume of 1,773,322 shares. Click Here to get the full Stock Report for Editas Medicine Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App